Ignite Creation Date:
2025-12-24 @ 2:13 PM
Ignite Modification Date:
2026-02-11 @ 7:35 AM
Study NCT ID:
NCT00566995
Status:
COMPLETED
Last Update Posted:
2018-10-30
First Post:
2007-12-01
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Phase II Study of Vandetanib in Individuals With Kidney Cancer
Sponsor:
National Cancer Institute (NCI)
Organization:
Organization Data
Organization:
Class:
NIH
Study ID:
080020
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
NIH
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None